|
|
| | | | Dear colleagues,
| | | | | | We are pleased to inform you that the detailed program of ISHL13 can now be accessed online.
| | | | |
|
|
| | | | Curated by the ISHL13 Scientific Committee, the program aims to provide a comprehensive overview and discussion of the latest advances in research, diagnostics and treatment of Hodgkin Lymphoma with distinguished speakers from around the globe. In addition to the scientific sessions and several satellite symposia, a joint session by the GHSG and the EHA Lymphoma Working Group addressing emerging therapeutic concepts in B-cell lymphomas will complement the program.
| | | | |
|
| | | | Submit your abstract now. | | | | | | The abstract submission to present your research at the premier scientific forum on Hodgkin Lymphoma is already open.
| | | | | | To present your research at ISHL13, it is essential to submit your abstract online before May 31, 2024, 23:59 (Europe/Berlin).
| | | | | | Awards will be granted to the best abstracts and presenting authors be distinguished during the opening ceremony of the congress.
| | | | |
|
| | | | Early Bird Registration | | | | | | Early bird registration for ISHL13 will end on July 15, 2024.
| | | | | | To ensure a quick and correct processing of your registration information, please use the online registration at www.hodgkinsymposium.org.
| | | | | | Alternatively, you can contact our organizational team at info@hodgkinsymposium.org.
| | | | |
|
| | | | ISHL13 will take place from October 26 to 28, 2024 in Cologne, Germany. Please visit our website for further information.
| | | | |
|
| All the best
| | | | | | Peter Borchmann, MD,
Symposium and GHSG Chairman | |
Sven Borchmann, MD/PhD,
Symposium Co-Chair | |
Paul J. Bröckelmann, MD,
Symposium Co-Chair | |
Dennis Eichenauer, MD,
Symposium Co-Chair | |
| | | | |
|
|
|